Brief: Perspective Announces Presentation Of Positive Early Clinical Data For VMT-α-NET
12/09/2023 14:33
Sept 12 (Reuters) - Perspective Therapeutics Inc
CATX.A :
* PERSPECTIVE ANNOUNCES PRESENTATION OF POSITIVE EARLY
CLINICAL
DATA FOR VMT-Α-NET
* PERSPECTIVE THERAPEUTICS INC: NO SIGNIFICANT RENAL OR
HEPATIC
FUNCTION ADVERSE EVENTS HAVE BEEN OBSERVED TO DATE
Source text for Eikon: ID:nGNX1j66N9
Further company coverage: CATX.A
((reuters.briefs@thomsonreuters.com;))
Recent news on Perspective Therapeutics
See all newsPerspective Therapeutics Q2 net loss widens on higher R&D costs
Brief: Perspective Therapeutics Q2 EPS USD -0.22
Brief: Perspective Therapeutics Expands Therapeutic Focus Areas First Patient Dosed With Vmt-Α-Net In The Meningioma Cohort Of A Phase 1/2A Study
Brief: Perspective Therapeutics Q1 EPS USD -0.25
Perspective Therapeutics rises as experimental cancer drug shows promise